Evolution of Lipid Abnormalities in Patients Switched From Stavudine- to Tenofovir-Containing Regimens
- 1 August 2003
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 33 (4) , 544-546
- https://doi.org/10.1097/00126334-200308010-00018
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Switching Effective Antiretroviral Therapy: A ReviewClinical Infectious Diseases, 2002
- Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: ‘a call for cardiovascular prevention’Atherosclerosis, 2002
- Abacavir Substitution for Nucleoside Analogs in Patients With HIV LipoatrophyA Randomized TrialJAMA, 2002
- Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus--Infected PatientsClinical Infectious Diseases, 2002
- Endocrine and Metabolic Evaluation of Human Immunodeficiency Virus-Infected Patients with Evidence of Protease Inhibitor-Associated LipodystrophyJournal of Clinical Endocrinology & Metabolism, 1999